ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,553.40
-1.16%
S&P ASX All Technology
2,933.70
-0.95%
Brent Oil
88.175
2.04%
US Dollar vs AUD
1.56276
0.40%
Bitcoin
62,163.52
-2.12%
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. Bristol Myers Squibb Co (BMY)

  7. Bristol Myers Squibb Co (BMY) News

BMY Bristol Myers Squibb Co

48.19
0.35 (0.73%)
19 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Bristol Myers Squibb Co BMY NYSE Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.35 0.73% 48.19 10:00:00
Open Price Low Price High Price Close Price Previous Close
47.94 47.615 48.405 48.30 47.84
more quote information »

Recent News

Date Time Source Heading
09/4/202401:30BWKRAZATI (adagrasib) in Combination with Cetuximab..
07/4/202403:15BWBristol Myers Squibb Presents New Interim Long-Term Efficacy..
06/4/202400:05BWU.S. FDA Approves Bristol Myers Squibb and 2seventy bio’s..
03/4/202411:08BWEuropean Commission Expands Approval of Bristol Myers..
02/4/202421:59BWBristol Myers Squibb Releases 2023 Environmental, Social and..
29/3/202407:05BWBristol Myers Squibb Announces Pivotal KRYSTAL-12..
29/3/202407:01BWBristol Myers Squibb Provides Update on the First Phase 3..
28/3/202422:30GLOBEPerspective Therapeutics Provides Recent Business Highlights..
27/3/202405:25BWA Bristol Myers Squibb Expande as Iniciativas de Doações..
26/3/202421:59BWBristol Myers Squibb Expands Health Equity Grant Initiatives..
25/3/202423:00BWBristol Myers Squibb to Present Data at the American College..
21/3/202407:45BWBristol Myers Squibb’s Abecma (idecabtagene vicleucel)..
20/3/202421:59BWBristol Myers Squibb Announces CheckMate -9DW Trial..
19/3/202421:59BWBristol Myers Squibb and Ted Danson Empower Those with..
18/3/202423:44BWBristol Myers Squibb Completes Acquisition of Karuna..
16/3/202409:27BWFDA Advisory Committee Votes in Favor of Bristol Myers..
15/3/202412:35BWU.S. FDA Approves Bristol Myers Squibb’s Breyanzi® as the..
12/3/202407:16BWBristol Myers Squibb to Report Results for First Quarter..
08/3/202406:23BWU.S. Food and Drug Administration Approves Opdivo®..
07/3/202408:17BWBristol Myers Squibb to Participate in Upcoming Investor..
05/3/202409:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202409:52EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/3/202408:16BWBristol Myers Squibb Announces Dividend
29/2/202422:59BWBristol Myers Squibb Announces New Data from the Long-Term..
27/2/202408:16BWBristol Myers Squibb to Participate in the TD Cowen 44th..
27/2/202400:35BWBristol Myers Squibb Completes Acquisition of RayzeBio,..
24/2/202410:03EDGAR2Form 3 - Initial statement of beneficial ownership of..
23/2/202423:34EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
23/2/202422:59BWBristol Myers Squibb Receives Positive CHMP Opinion for..
23/2/202408:15EDGAR2Form 8-K - Current report
20/2/202422:59BWU.S. Food and Drug Administration (FDA) Accepts Supplemental..
15/2/202411:57BWBristol Myers Squibb Prices $13 Billion of Senior Unsecured..
15/2/202408:16BWBristol Myers Squibb Recommends Stockholders Reject..
14/2/202422:59BWU.S. Food and Drug Administration Accepts for Priority..
12/2/202422:59BWBristol Myers Squibb and RayzeBio Announce Expiration of HSR..
07/2/202422:59BWBristol Myers Squibb Announces Acceptance of U.S. and EU..
06/2/202401:00BWBristol Myers Squibb Named One of America’s Most JUST..
05/2/202422:59BWBristol Myers Squibb and 2seventy bio Share Update on U.S...
02/2/202422:59BWBristol Myers Squibb Reports Fourth Quarter and Full-Year..
30/1/202422:59BWRegulatory Applications Accepted in the U.S. and Japan for..
28/1/202402:00BWSubcutaneous Nivolumab (nivolumab and hyaluronidase) Shows..
26/1/202423:13BWBristol Myers Squibb Receives Positive CHMP Opinion for CAR..
26/1/202400:13EDGAR2Form SC TO-T - Tender offer statement by Third Party
24/1/202400:30BWBristol Myers Squibb Completes Acquisition of Mirati..
23/1/202409:05BWEight-Year Data for Opdivo (nivolumab) Plus Yervoy..
23/1/202409:00BWOpdivo® (nivolumab) in Combination with CABOMETYX®..
21/1/202402:00BWOpdivo (nivolumab) Plus Yervoy (ipilimumab) Reduced the Risk..
17/1/202422:59BWBristol Myers Squibb Data at ASCO GU 2024 Showcase..
09/1/202422:12IHMARKETNEWSWall Street Highlights: HPE and Juniper Networks in..
09/1/202403:46DJNBristol Myers Reaffirms Long-Term Financial Targets

Your Recent History

NYSE
BMY
Bristol Myers Squibb
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved